Trust Company of Toledo’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $695K | Buy |
3,217
+252
| +8% | +$48.2K | 0.06% | 209 |
|
|
2026
Q1 | $544K | Buy |
2,965
+458
| +18% | +$84.4K | 0.05% | 215 |
|
|
2025
Q4 | $441K | Buy |
2,507
+468
| +23% | +$76.5K | 0.04% | 221 |
|
|
2025
Q3 | $286K | Sell |
2,039
-186
| -8% | -$25.1K | 0.03% | 251 |
|
|
2025
Q2 | $279K | Sell |
2,225
-39
| -2% | -$4.86K | 0.03% | 246 |
|
|
2025
Q1 | $310K | Buy |
2,264
+252
| +13% | +$36K | 0.04% | 204 |
|
|
2024
Q4 | $308K | Sell |
2,012
-203
| -9% | -$34.2K | 0.04% | 200 |
|
|
2024
Q3 | $429K | Buy |
2,215
+6
| +0.3% | +$1.25K | 0.06% | 183 |
|
|
2024
Q2 | $512K | Buy |
2,209
+222
| +11% | +$48.2K | 0.07% | 168 |
|
|
2024
Q1 | $428K | Sell |
1,987
-988
| -33% | -$231K | 0.07% | 170 |
|
|
2023
Q4 | $770K | Buy |
2,975
+235
| +9% | +$57.7K | 0.13% | 139 |
|
|
2023
Q3 | $704K | Sell |
2,740
-238
| -8% | -$63.7K | 0.14% | 138 |
|
|
2023
Q2 | $848K | Buy |
2,978
+1,108
| +59% | +$330K | 0.14% | 122 |
|
|
2023
Q1 | $520K | Buy |
+1,870
| New | +$517K | 0.09% | 142 |
|
|
2020
Q2 | – | Sell |
-679
| Closed | -$215K | – | 172 |
|
|
2020
Q1 | $215K | Hold |
679
| – | – | 0.06% | 154 |
|
|
2019
Q4 | $201K | Buy |
+679
| New | +$188K | 0.05% | 170 |
|
|
2019
Q1 | – | Sell |
-665
| Closed | -$200K | – | 180 |
|
|
2018
Q4 | $200K | Hold |
665
| – | – | 0.06% | 165 |
|
|
2018
Q3 | $235K | Buy |
+665
| New | +$229K | 0.06% | 168 |
|
|
2018
Q1 | – | Sell |
-665
| Closed | -$212K | – | 187 |
|
|
2017
Q4 | $212K | Hold |
665
| – | – | 0.05% | 186 |
|
|
2017
Q3 | $208K | Buy |
+665
| New | +$197K | 0.05% | 179 |
|
|
2016
Q4 | – | Sell |
-645
| Closed | -$202K | – | 184 |
|
|
2016
Q3 | $202K | Buy |
+645
| New | +$191K | 0.06% | 174 |
|
|
2015
Q3 | – | Sell |
-645
| Closed | -$260K | – | 168 |
|
|
2015
Q2 | $260K | Hold |
645
| – | – | 0.08% | 165 |
|
|
2015
Q1 | $273K | Hold |
645
| – | – | 0.08% | 158 |
|
|
2014
Q4 | $219K | Hold |
645
| – | – | 0.07% | 170 |
|
|
2014
Q3 | $213K | Hold |
645
| – | – | 0.07% | 170 |
|
|
2014
Q2 | $204K | Buy |
+645
| New | +$194K | 0.06% | 172 |
|
|
2014
Q1 | – | Sell |
-845
| Closed | -$236K | – | 179 |
|
|
2013
Q4 | $236K | Hold |
845
| – | – | 0.08% | 174 |
|
|
2013
Q3 | $203K | Buy |
+845
| New | +$189K | 0.07% | 178 |
|
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
Trust Company of Toledo's BIIB Position: Q2 2026 in Review
Trust Company of Toledo increased its Biogen (BIIB) stake by 8.5% in Q2 2026, buying an estimated $48.2K and bringing the position to 3,217 shares worth $695K. The position accounts for 0.06% of the portfolio, ranked #209.
Trust Company of Toledo first reported a position in BIIB in Q3 2013 and has held it in 28 quarters since. The position peaked at $848K in Q2 2023. 383 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Trust Company of Toledo held 3,217 shares of Biogen worth $695K as of Q2 2026.
- Trust Company of Toledo bought 252 Biogen shares in Q2 2026, an estimated $48.2K.
- Biogen made up 0.06% of Trust Company of Toledo's portfolio in Q2 2026, its #209 holding.
- Trust Company of Toledo first reported a position in Biogen in Q3 2013 and has held it in 28 quarters since.
- Trust Company of Toledo's Biogen position peaked at $848K in Q2 2023.
- 383 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.